69 related articles for article (PubMed ID: 21549693)
1. ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptors.
Riccioni T; Bordi F; Minetti P; Spadoni G; Yun HM; Im BH; Tarzia G; Rhim H; Borsini F
Eur J Pharmacol; 2011 Jul; 661(1-3):8-14. PubMed ID: 21549693
[TBL] [Abstract][Full Text] [Related]
2. Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain.
Borsini F; Bordi F; Poggi A; Di Matteo V
J Psychopharmacol; 2015 Jul; 29(7):802-11. PubMed ID: 25735994
[TBL] [Abstract][Full Text] [Related]
3. A microdialysis study of ST1936, a novel 5-HT6 receptor agonist.
Valentini V; Frau R; Bordi F; Borsini F; Di Chiara G
Neuropharmacology; 2011 Mar; 60(4):602-8. PubMed ID: 21185318
[TBL] [Abstract][Full Text] [Related]
4. Tonic inhibitory role for cAMP in alpha(1a)-adrenergic receptor coupling to extracellular signal-regulated kinases 1/2.
Jiao X; Gonzalez-Cabrera PJ; Xiao L; Bradley ME; Abel PW; Jeffries WB
J Pharmacol Exp Ther; 2002 Oct; 303(1):247-56. PubMed ID: 12235258
[TBL] [Abstract][Full Text] [Related]
5. Endogenous expression and protein kinase A-dependent phosphorylation of the guanine nucleotide exchange factor Ras-GRF1 in human embryonic kidney 293 cells.
Norum JH; Méthi T; Mattingly RR; Levy FO
FEBS J; 2005 May; 272(9):2304-16. PubMed ID: 15853814
[TBL] [Abstract][Full Text] [Related]
6. 5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events.
Yun HM; Rhim H
Toxicol In Vitro; 2011 Dec; 25(8):2035-40. PubMed ID: 21864673
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1).
Fang Y; Olah ME
J Pharmacol Exp Ther; 2007 Sep; 322(3):1189-200. PubMed ID: 17565009
[TBL] [Abstract][Full Text] [Related]
8. Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C.
Lembo PM; Albert PR
Mol Pharmacol; 1995 Dec; 48(6):1024-9. PubMed ID: 8848001
[TBL] [Abstract][Full Text] [Related]
9. Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway.
Péqueux C; Keegan BP; Hagelstein MT; Geenen V; Legros JJ; North WG
Endocr Relat Cancer; 2004 Dec; 11(4):871-85. PubMed ID: 15613460
[TBL] [Abstract][Full Text] [Related]
10. The Role of 5-HTR6 in Mossy Fiber Sprouting: Activating Fyn and p-ERK1/2 in Pilocarpine-Induced Chronic Epileptic Rats.
Lin W; Huang W; Chen S; Lin M; Huang Q; Huang H
Cell Physiol Biochem; 2017; 42(1):231-241. PubMed ID: 28535499
[TBL] [Abstract][Full Text] [Related]
11. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
Cussac D; Duqueyroix D; Newman-Tancredi A; Millan MJ
Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of 5HT(2C) receptor-mediated ERK1/2 phosphorylation: agonist-specific activation pathways and the impact of RNA editing.
Werry TD; Stewart GD; Crouch MF; Watts A; Sexton PM; Christopoulos A
Biochem Pharmacol; 2008 Nov; 76(10):1276-87. PubMed ID: 18812172
[TBL] [Abstract][Full Text] [Related]
13. Ligand-induced activation of ERK1/2 signaling by constitutively active G
Liu P; Yin YL; Wang T; Hou L; Wang XX; Wang M; Zhao GG; Shi Y; Xu HE; Jiang Y
Acta Pharmacol Sin; 2019 Sep; 40(9):1157-1167. PubMed ID: 30833707
[TBL] [Abstract][Full Text] [Related]
14. Alpha7 nAChR-mediated activation of MAP kinase pathways in PC12 cells.
Gubbins EJ; Gopalakrishnan M; Li J
Brain Res; 2010 Apr; 1328():1-11. PubMed ID: 20211606
[TBL] [Abstract][Full Text] [Related]
15. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
Kim HJ; Yun HM; Kim T; Nam G; Roh EJ; Kostenis E; Choo HY; Pae AN; Rhim H
Comb Chem High Throughput Screen; 2008 May; 11(4):316-24. PubMed ID: 18473741
[TBL] [Abstract][Full Text] [Related]
16. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways.
Romero G; Sánchez E; Pujol M; Pérez P; Codony X; Holenz J; Buschmann H; Pauwels PJ
Br J Pharmacol; 2006 Aug; 148(8):1133-43. PubMed ID: 16865095
[TBL] [Abstract][Full Text] [Related]
18. The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn.
Yun HM; Kim S; Kim HJ; Kostenis E; Kim JI; Seong JY; Baik JH; Rhim H
J Biol Chem; 2007 Feb; 282(8):5496-505. PubMed ID: 17189269
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
Mattsson C; Svensson P; Boettcher H; Sonesson C
Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin causes over-expression of tachykinin NK(1) receptors and increases ERK1/2- and PKA- phosphorylation during peak immediate- and delayed-phase emesis in the least shrew (Cryptotis parva) brainstem.
Darmani NA; Dey D; Chebolu S; Amos B; Kandpal R; Alkam T
Eur J Pharmacol; 2013 Jan; 698(1-3):161-9. PubMed ID: 23001014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
